Insider · CIK 0001929938
John Kleckner
officer
Files at ENOV (Enovis CORP). First filing Nov 28, 2025, latest Nov 28, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$75k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ENOV: Enovis CORP
ENOVOct 9, 2026 · close 17.69
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | ENOVbuy Enovis CORP | $75k 2,468 shares | +25% | +18% from low-38% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | ENOV Enovis CORP | POpen-market purchase Common stock, par value $0.001 | +2,468 | $30.32 | $75k | 12,302 | Nov 28, 2025 |
| Aug 5, 2025 | ENOV Enovis CORP | FTax withholding Common stock, par value $0.001 | -173 | $26.46 | $4,578 | 9,834 | Aug 7, 2025 |
| Mar 7, 2025 | ENOV Enovis CORP | AGrant or award Common stock, par value $0.001 | +4,459 | $0.00 | $0 | 10,007 | Mar 11, 2025 |
| Mar 4, 2025 | ENOV Enovis CORP | FTax withholding Common stock, par value $0.001 | -442 | $36.62 | $16k | 5,548 | Mar 6, 2025 |
| Feb 28, 2025 | ENOV Enovis CORP | FTax withholding Common stock, par value $0.001 | -316 | $38.65 | $12k | 5,990 | Mar 4, 2025 |
| Feb 17, 2025 | ENOV Enovis CORP | FTax withholding Common stock, par value $0.001 | -178 | $43.89 | $7,812 | 6,306 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.